Related Experiment Video
Updated: Mar 25, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
Benzoxaborole-modified azithromycins inhibit translation without inducing ermC expression.
Inna A Volynkina1,2, Michael O Bortyazh1,3, Chih-Wei Chen4
1Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
New antibacterial agents combat resistance by modifying azithromycin (AZI). These AZI-benzoxaborole conjugates inhibit bacterial translation and prevent resistance by altering ribosome interactions, unlike traditional macrolides.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Molecular Biology
Background:
- Antimicrobial resistance necessitates novel antibacterial agents.
- Azithromycin (AZI) is a macrolide antibiotic scaffold for developing new drugs.
- Mechanisms of AZI derivatives are not fully understood.
Purpose of the Study:
- Characterize the activity and mechanism of novel AZI-benzoxaborole (AZI-BB) conjugates.
- Investigate their efficacy against macrolide-resistant bacteria.
- Elucidate how modifications affect ribosome interaction and resistance induction.
Main Methods:
- In vitro translation inhibition assays.
- Testing against an Escherichia coli strain with an inducible macrolide resistance operon.
- High-throughput toeprinting with deep sequencing (Toe-seq).
- Structural analysis of AZI-BB2-ribosome interactions.
Main Results:
- AZI-BB conjugates inhibit bacterial translation and retain activity against resistant E. coli.
- Compounds show minimal induction of the ErmC resistance protein.
- Structural analysis reveals unique interactions of AZI-BB2 with 23S rRNA, causing premature ribosome stalling.
- AZI-BB2 displays reduced sequence specificity for resistance-conferring motifs.
Conclusions:
- Targeted modification of AZI can alter its ribosome binding and attenuate resistance mechanisms.
- AZI-benzoxaborole conjugates represent a promising strategy for overcoming macrolide resistance.
- Understanding these mechanistic shifts is crucial for designing next-generation antibiotics.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Leaky Scanning
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Inhibitors of Gram-positive Cell Wall Synthesis

